arrow
V

Vı́ctor Obach

hospital clinic
H指数:44
被引数:7,652

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real-life multicenter study

Galcanezumab预防≥65岁患者偏头痛的有效性与耐受性:一项真实世界多中心研究

IF0
2025-10-140
OAAI
Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

西班牙人群的性别分层全基因组关联研究确定了腔隙性卒中的新位点

STROKE
IF8.9
2024-10-010
PRE
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
2024-05-2210
PRE
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

中风治疗后止血因素和出血转化的多性状遗传研究

2024-04-012
OAAI
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
2023-11-223
OAAI
Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke
BRAIN
IF11.7
2022-02-2514
OA
Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry
stroke
IF8.6
2021-09-300
OAAI
RP11-362K2.2:RP11-767I20.1 Genetic Variation Is Associated with Post-Reperfusion Therapy Parenchymal Hematoma. A GWAS Meta-Analysis
2021-07-167
OAAI
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
BRAIN
IF11.7
2021-03-1610
OA
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome
STROKE
IF8.9
2021-01-0139
OAAI
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
2020-02-188
OAAI